MDGL
Madrigal Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$535.69-3.21%
Price as of Jul 20, 2026
MDGL analysis
Madrigal Pharmaceuticals, Inc. stock analysis
Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.
Analysis for MDGL is not published yet
Browse the public research library while company-specific analysis is being prepared. Explore research